Home Industries Market Insights About Us Publisher Contact us

AI in Bioinformatics Market Growth, Trends, and Forecast to 2028 – Global Analysis By Offering (Software, and Services), By Division (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others), By End-use Application (Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics, and Others) and By Geography

Categories: Life Science   |   Formate :

MARKET DEFINITION 

Using computer technology to gather, store, analyze, and share biological data and information, such as DNA and amino acid sequences or annotations about those sequences, comes under the field of bioinformatics. The function of data analysis in the information and Internet age can be paralleled to the function of bioinformatics in biological research. AI in bioinformatics uses biological sequence matching, protein-protein interaction, and function-structure analysis to aid in both fundamental and clinical research. This approach aids in the development of complex systems and the creation of pharmaceuticals.

MARKET DYNAMICS 

Globally, numerous public and private entities are investing more and more in the field of bioinformatics. The quality of these services has increased as a result of these investments, which have mostly led to data and technological breakthroughs in bioinformatics services. Next-generation sequencing (NGS) is developing as a powerful tool for providing a deeper and more precise insight. However, the cost of the AI-based bioinformatics instrument is high as it requires extensive validation and other specifications. On the other hand, in the coming years, it is anticipated that the growing investments of emerging economies in R&D from global players are expected to offer favorable prospects along with opportunities for the growth of precision medicine, drug discovery, genomics and other markets.

REPORT SCOPE 

The report titled “Global AI in Bioinformatics Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global AI in Bioinformatics market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global AI in the Bioinformatics market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global AI in Bioinformatics Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW 

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

 

MARKET SEGMENTATION 

The Global AI in Bioinformatics Market is segmented based on offering, division, end-use application, and region. Based on offering, the market has been segmented into Software, and Services, whereas based on division, the market comprises Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, and Others. Based on end-use application, the market has been segmented into Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics, and Others.

COMPETITION LANDSCAPE 

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by AI in Bioinformatics market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global AI in the Bioinformatics market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global AI in the Bioinformatics market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in AI in the Bioinformatics industry in the past three years.

Key players in the Global AI in Bioinformatics Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

·         Ardigen

·         SOPHiA GENETICS

·         Biomax Informatics Inc.

·         DNASTAR

·         Source BioScience

·         QIAGEN

·         NeoGenomics Laboratories,

·         Celbridge Science

·         Illumina, Inc.

·         Thermo Fisher Scientific, Inc.

·         Insilico

·         Strand Life Sciences

·         Paige AI, Inc.

·         Others

COVID-19 IMPACT ANALYSIS ON GLOBAL AI IN BIOINFORMATICS MARKET 

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as the broader market, thereby, providing accurate and trustworthy forecasts.

 

Report Attribute/Metric

Details

Market Size

In USD Million

CAGR

In % (2022-2028)

Base Year

2021

Forecast Period

2022 – 2028

Historical Data

2017 to 2021

Forecast Unit

Value (US$ Mn)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors and Trends

Geographies Covered

North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Key Players Analyzed

Ardigen, SOPHiA GENETICS, Biomax Informatics Inc., DNASTAR , Source BioScienc, QIAGEN, NeoGenomics Laboratories, Celbridge Science, Illumina, Inc., Thermo Fisher Scientific, Inc. , Insilico, Strand Life Sciences, Paige AI, Inc., and Others

Customization & Pricing

Available on Request (10% Customization is Free)

 

RESEARCH PROGRAM DESIGN

 

KEY QUESTIONS ANSWERED 

1.    What is the current size of the global AI in Bioinformatics market?

2.    What will be the growth rate of the market over the forecast period?

3.    Who are the key manufacturers/vendors in the AI in Bioinformatics market space?

4.    What are the major market opportunities and market risks faced by the market?

5.    What is the impact of COVID-19 on the market?

6.    What are the revenue, sales, and price analysis of the top manufacturers in this market?

7.    What are the key outcomes of Porter's five forces model?

8.    Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT

·         The report offers comprehensive data on the AI in Bioinformatics market elaborating on the current state and future growth prospects both globally and regionally

·         It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth

·         The report offers deep-dive insights into each market segment and critical factors responsible for its growth

·         The report presents a precise picture of the dynamic competitive landscape which helps our client advance their market position

·         The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions

·         Cross-segment country-level analysis is included in the report which provides granular analysis of more than 20+ countries covered in the report's scope

·         The study includes detailed profiles of major manufacturers to help our readers gain a holistic overview of the market competitors and consequently align their business strategies

 

 

Chapter 1.  Executive Summary

1.1.   Market Outlook

1.2.   Market Segment Outlook

1.3.   Geography Outlook

1.4.   Absolute $ Opportunity

Chapter 2.  Research Methodology

2.1.   Research Approach

2.2.   Scope, Definition, and Assumptions

2.3.   Data Sources

2.3.1. Secondary Sources

2.3.1.1.         Preliminary Data Mining

2.3.2. Primary Sources

2.3.2.1.         Statistical End-use Application

2.3.2.2.         Data Triangulation

2.3.2.3.         Research Objective

Chapter 3.  Market Outlook

3.1.   Introduction

3.2.   Key Trends

3.2.1. Offering Trends

3.2.2. Division Trends

3.2.3. End-use Application Trends

3.3.   Market Dynamics

3.3.1. Market Drivers

3.3.1.1.         Impact Analysis of Market Drivers

3.3.2. Market Restraints

3.3.2.1.         Impact Analysis of Market Restraints

3.3.3. Market Opportunities

3.3.3.1.         Impact Analysis of Market Opportunities

3.3.4. Market Challenges

3.3.4.1.         Impact Analysis of Market Challenges

3.4.   Porter’s Five Forces’ Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of New Entrant

3.4.4. Threat of Substitutes

3.4.5. Competitive Rivalry

3.5.   Value Chain Analysis: Global AI in Bioinformatics Market

3.6.   COVID-19 Impact Assessment in AI in Bioinformatics Market

3.6.1. Impact Assessment on Global AI in Bioinformatics Market

3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4.  Global AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

4.1.   Global AI in Bioinformatics Market Share, By Offering, 2017 - 2028 (USD Million)

4.1.1. Software

4.1.2. Services

Chapter 5.  Global AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

5.1.   Global AI in Bioinformatics Market Share, By Division, 2017 - 2028 (USD Million)

5.1.1. Medical Biotechnology

5.1.2. Animal Biotechnology

5.1.3. Plant Biotechnology

5.1.4. Environmental Biotechnology

5.1.5. Forensic Biotechnology

5.1.6. Others

Chapter 6.       Global AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

6.1.   Global AI in Bioinformatics Market Share, By End-use Application, 2017 - 2028 (USD Million)

6.1.1. Genomics

6.1.2. Chemoinformatics & Drug Design

6.1.3. Proteomics

6.1.4. Transcriptomics

6.1.5. Metabolomics

6.1.6. Others

Chapter 7.  Global AI in Bioinformatics Market Overview, By Geography, 2017 - 2028 (USD Million)

7.1.   Global AI in Bioinformatics Market Share, By Geography, 2017 - 2028 (USD Million)

7.1.1. Market Division and Projections, by Countries, 2017 - 2028 (USD Million)

7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 8.  North America AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

8.1.     North America AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

8.1.1.     Market Division and projections, 2017 - 2028 (USD Million)

8.1.2.     North America AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

8.1.3.     North America AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

8.1.4.     North America AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

8.2.     North America AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

8.2.1.     U.S. AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

8.2.1.1.         U.S. AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

8.2.1.2.         U.S. AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

8.2.1.3.         U.S. AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

8.2.2.     Canada AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

8.2.2.1.         Canada AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

8.2.2.2.         Canada AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

8.2.2.3.         Canada AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

8.2.3.     Mexico AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

8.2.3.1.         Mexico AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

8.2.3.2.         Mexico AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

8.2.3.3.         Mexico AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

Chapter 9.  Europe AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

9.1.     Europe AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.1.1. Market Division and projections, 2017 - 2028 (USD Million)

9.1.2.     Europe AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.1.3.     Europe AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.1.4.     Europe AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.     Europe AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

9.2.1.     Germany AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.1.1.         Germany AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.1.2.         Germany AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.1.3.         Germany AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.2.     France AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.2.1.         France AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.2.2.         France AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.2.3.         France AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.3.     UK AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.3.1.         UK AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.3.2.         UK AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.3.3.         UK AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.4.     Italy AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.4.1.         Italy AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.4.2.         Italy AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.4.3.         Italy AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.5.     Spain AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.5.1.         Spain AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.5.2.         Spain AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.5.3.         Spain AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.6.     NORDIC AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.6.1.         NORDIC AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.6.2.         NORDIC AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.6.3.         NORDIC AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.7.     Russia and CIS AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.7.1.         Russia and CIS AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.7.2.         Russia and CIS AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.7.3.         Russia and CIS AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

9.2.8.     Rest of Europe AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

9.2.8.1.         Rest of Europe AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

9.2.8.2.         Rest of Europe AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

9.2.8.3.         Rest of Europe AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

Chapter 10.      Asia Pacific AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

10.1.  Asia Pacific AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.1.1.   Market Division and projections, 2017 - 2028 (USD Million)

10.1.2.   Asia Pacific AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.1.3.   Asia Pacific AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.1.4.   Asia Pacific AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

10.2.  Asia Pacific AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

10.2.1.   India AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.2.1.1.       India AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.1.2.       India AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.2.1.3.       India AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

10.2.2.   China AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.2.2.1.       China AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.2.2.       China AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.2.2.3.       China AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

10.2.3.   Japan AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.2.3.1.       Japan AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.3.2.       Japan AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.2.3.3.       Japan AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

10.2.4.   ASEAN AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.2.4.1.       ASEAN AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.4.2.       ASEAN AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.2.4.3.       ASEAN AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

10.2.5.   South Korea AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.2.5.1.       South Korea AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.5.2.       South Korea AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.2.5.3.       South Korea AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

10.2.6.   Australia AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.2.6.1.       Australia AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.6.2.       Australia AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.2.6.3.       Australia AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

10.2.7.   Rest of Asia Pacific AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

10.2.7.1.       Rest of Asia Pacific AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

10.2.7.2.       Rest of Asia Pacific AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

10.2.7.3.       Rest of Asia Pacific AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

Chapter 11.      South America AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

11.1.  South America AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

11.1.1.   Market Division and projections, 2017 - 2028 (USD Million)

11.1.2.   South America AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

11.1.3.   South America AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

11.1.4.   South America AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

11.2.  South America AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

11.2.1.   Brazil AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

11.2.1.1.       Brazil AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.1.2.       Brazil AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

11.2.1.3.       Brazil AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

11.2.2.   Argentina AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

11.2.2.1.       Argentina AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.2.2.       Argentina AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

11.2.2.3.       Argentina AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

11.2.3.   Rest of South America AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

11.2.3.1.       Rest of South America AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

11.2.3.2.       Rest of South America AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

11.2.3.3.       Rest of South America AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

Chapter 12.      Middle East & Africa AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

12.1.  Middle East & Africa AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

12.1.1.   Market Division and projections, 2017 - 2028 (USD Million)

12.1.2.   Middle East & Africa AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

12.1.3.   Middle East & Africa AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

12.1.4.   Middle East & Africa AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

12.2.  Middle East & Africa AI in Bioinformatics Market Overview, By Countries, 2017 - 2028 (USD Million)

12.2.1.   GCC AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

12.2.1.1.       GCC AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

12.2.1.2.       GCC AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

12.2.1.3.       GCC AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

12.2.2.   South Africa AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

12.2.2.1.       South Africa AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

12.2.2.2.       South Africa AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

12.2.2.3.       South Africa AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

12.2.3.   Rest of Middle East & Africa AI in Bioinformatics Market Overview, 2017 - 2028 (USD Million)

12.2.3.1.       Rest of Middle East & Africa AI in Bioinformatics Market Overview, By Offering, 2017 - 2028 (USD Million)

12.2.3.2.       Rest of Middle East & Africa AI in Bioinformatics Market Overview, By Division, 2017 - 2028 (USD Million)

12.2.3.3.       Rest of Middle East & Africa AI in Bioinformatics Market Overview, By End-use Application, 2017 - 2028 (USD Million)

Chapter 13.      Competitive Landscape

13.1.  Competitive Environment, 2021

13.2.  Strategic Framework

13.2.1.   Partnership/Collaborations/Agreement

13.2.2.   Expansion

13.2.3.   Mergers & Acquisitions

13.2.4.   New Product Development

Chapter 14.      Key Vendor Analysis

14.1.              Ardigen

14.1.1.       Business Overview

14.1.2.       Product Benchmarking

14.1.3.       Financial Data

14.1.4.       Strategic Overview

14.1.5.       Key Developments

14.1.6.       SWOT Analysis

14.2.              SOPHiA GENETICS

14.2.1.       Business Overview

14.2.2.       Product Benchmarking

14.2.3.       Financial Data

14.2.4.       Strategic Overview

14.2.5.       Key Developments

14.2.6.       SWOT Analysis

14.3.              Biomax Informatics Inc.

14.3.1.       Business Overview

14.3.2.       Product Benchmarking

14.3.3.       Financial Data

14.3.4.       Strategic Overview

14.3.5.       Key Developments

14.3.6.       SWOT Analysis

14.4.              DNASTAR  

14.4.1.       Business Overview

14.4.2.       Product Benchmarking

14.4.3.       Financial Data

14.4.4.       Strategic Overview

14.4.5.       Key Developments

14.4.6.       SWOT Analysis

14.5.              Source BioScienc

14.5.1.       Business Overview

14.5.2.       Product Benchmarking

14.5.3.       Financial Data

14.5.4.       Strategic Overview

14.5.5.       Key Developments

14.5.6.       SWOT Analysis

14.6.              QIAGEN

14.6.1.       Business Overview

14.6.2.       Product Benchmarking

14.6.3.       Financial Data

14.6.4.       Strategic Overview

14.6.5.       Key Developments

14.6.6.       SWOT Analysis

14.7.              NeoGenomics Laboratories

14.7.1.       Business Overview

14.7.2.       Product Benchmarking

14.7.3.       Financial Data

14.7.4.       Strategic Overview

14.7.5.       Key Developments

14.7.6.       SWOT Analysis

14.8.              Celbridge Science

14.8.1.       Business Overview

14.8.2.       Product Benchmarking

14.8.3.       Financial Data

14.8.4.       Strategic Overview

14.8.5.       Key Developments

14.8.6.       SWOT Analysis

14.9.              Illumina, Inc.

14.9.1.       Business Overview

14.9.2.       Product Benchmarking

14.9.3.       Financial Data

14.9.4.       Strategic Overview

14.9.5.       Key Developments

14.9.6.       SWOT Analysis

14.10.            Thermo Fisher Scientific, Inc.  

14.10.1.    Business Overview

14.10.2.    Product Benchmarking

14.10.3.    Financial Data

14.10.4.    Strategic Overview

14.10.5.    Key Developments

14.10.6.    SWOT Analysis

14.11.            Insilico

14.11.1.    Business Overview

14.11.2.    Product Benchmarking

14.11.3.    Financial Data

14.11.4.    Strategic Overview

14.11.5.    Key Developments

14.11.6.    SWOT Analysis

14.12.            Strand Life Sciences

14.12.1.    Business Overview

14.12.2.    Product Benchmarking

14.12.3.    Financial Data

14.12.4.    Strategic Overview

14.12.5.    Key Developments

14.12.6.    SWOT Analysis

14.13.            Paige AI, Inc.

14.13.1.    Business Overview

14.13.2.    Product Benchmarking

14.13.3.    Financial Data

14.13.4.    Strategic Overview

14.13.5.    Key Developments

14.13.6.    SWOT Analysis

14.14.            Others

Chapter 15.   Future Outlook of the Market

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

AI in Bioinformatics Market Growth, Trends, and Fo...

RD Code : HP22